These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27780949)

  • 21. Identification and characterization of the Orf49 protein of Kaposi's sarcoma-associated herpesvirus.
    González CM; Wong EL; Bowser BS; Hong GK; Kenney S; Damania B
    J Virol; 2006 Mar; 80(6):3062-70. PubMed ID: 16501115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic Reprogramming of Kaposi's Sarcoma-Associated Herpesvirus during Hypoxic Reactivation.
    Singh RK; Bose D; Robertson ES
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposi's Sarcoma-Associated Herpesvirus Utilizes and Manipulates RNA N
    Ye F; Chen ER; Nilsen TW
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic Regulation of Kaposi's Sarcoma-Associated Herpesvirus Latency.
    Campbell M; Yang WS; Yeh WW; Kao CH; Chang PC
    Front Microbiol; 2020; 11():850. PubMed ID: 32508765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA.
    Chang M; Brown HJ; Collado-Hidalgo A; Arevalo JM; Galic Z; Symensma TL; Tanaka L; Deng H; Zack JA; Sun R; Cole SW
    J Virol; 2005 Nov; 79(21):13538-47. PubMed ID: 16227274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation.
    Strahan RC; McDowell-Sargent M; Uppal T; Purushothaman P; Verma SC
    PLoS Pathog; 2017 Jul; 13(7):e1006482. PubMed ID: 28678843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency.
    Ford PW; Bryan BA; Dyson OF; Weidner DA; Chintalgattu V; Akula SM
    J Gen Virol; 2006 May; 87(Pt 5):1139-1144. PubMed ID: 16603514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insight into the Epigenetics of Kaposi's Sarcoma-Associated Herpesvirus.
    Srivastava A; Srivastava A; Singh RK
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAN RNA: transcriptional exhaust from a viral engine.
    Campbell M; Izumiya Y
    J Biomed Sci; 2020 Mar; 27(1):41. PubMed ID: 32143650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Tip60 Reduces Lytic and Latent Gene Expression of Kaposi's Sarcoma-Associated Herpes Virus (KSHV) and Proliferation of KSHV-Infected Tumor Cells.
    Simpson S; Fiches G; Jean MJ; Dieringer M; McGuinness J; John SP; Shamay M; Desai P; Zhu J; Santoso NG
    Front Microbiol; 2018; 9():788. PubMed ID: 29740418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
    Yang Z; Wood C
    J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KSHV and the Role of Notch Receptor Dysregulation in Disease Progression.
    DeCotiis JL; Lukac DM
    Pathogens; 2017 Aug; 6(3):. PubMed ID: 28777778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular biology of KSHV lytic reactivation.
    Purushothaman P; Uppal T; Verma SC
    Viruses; 2015 Jan; 7(1):116-53. PubMed ID: 25594835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
    Purushothaman P; Thakker S; Verma SC
    J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysine residues of interferon regulatory factor 7 affect the replication and transcription activator-mediated lytic replication of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.
    Zhang T; Wang Y; Zhang L; Liu B; Xie J; Wood C; Wang J
    J Gen Virol; 2011 Jan; 92(Pt 1):181-7. PubMed ID: 20844090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
    Lan K; Kuppers DA; Robertson ES
    J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
    Ramalingam D; Happel C; Ziegelbauer JM
    J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.